You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Infliximab

Showing 1 - 25 of 765
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Crohn Disease, Infliximab, Perianal Fistula Due to Crohn's Disease Trial (TDM-based infliximab intravenous therapy, Standard

Not yet recruiting
  • Crohn Disease
  • +4 more
  • TDM-based infliximab intravenous therapy
  • Standard infliximab intravenous therapy
  • (no location specified)
Sep 26, 2023

IBD Trial in Paris (Biocollection)

Not yet recruiting
  • Inflammatory Bowel Diseases
  • Biocollection
  • Paris, France
    Saint Antoine Hospital Service de Gastroentérologie et Nutrition
Feb 1, 2023

Crohn Disease Trial in Beijing (Infliximab)

Not yet recruiting
  • Crohn Disease
  • Infliximab
  • Beijing, China
    Beijing Children's Hospital, Capital Medical University
Jun 13, 2023

Therapeutic Monitoring of Infliximab and Adalimumab

Recruiting
  • Inflammatory Bowel Diseases
  • Trieste, Italy
    IRCCS Burlo Garofolo
Sep 5, 2023

EFFICACY AND SAFETY OF S.C. INFLIXIMAB IN PATIENTS SWITCHED FROM

Recruiting
  • Inflammatory Bowel Diseases
  • Rheumatologic Disease
  • Milano, Italy
    Irccs Ospedale San Raffaele
Jan 30, 2023

Crohn Disease, Infliximab Trial (Azathioprine, Infliximab)

Not yet recruiting
  • Crohn Disease
  • Infliximab
  • (no location specified)
Apr 3, 2023

Hidradenitis Suppurativa Trial in Lahore (Infliximab biosimilar)

Active, not recruiting
  • Hidradenitis Suppurativa
  • Infliximab biosimilar
  • Lahore, Punjab, Pakistan
    Services Institute of Medical Sciences
Dec 22, 2022

Crohn's Disease, Exclusive Enteral Nutrition, Infliximab Trial (Infliximab, Exclusive Enteral Nutrition)

Withdrawn
  • Crohn's Disease
  • +3 more
  • Infliximab
  • Exclusive Enteral Nutrition
  • (no location specified)
Aug 5, 2022

A 24-month Real Life PErsistence Efficacy and Safety Study in

Recruiting
  • Inflammatory Bowel Diseases
  • Subcutaneous infliximab CT-P13 Remsima®SC
  • Grenoble, France
    Nicolas Mathieu
Aug 2, 2022

Crohn Disease, Child, Only, Biologic; Inadequate Trial (Infliximab)

Not yet recruiting
  • Crohn Disease
  • +2 more
  • Infliximab
  • (no location specified)
Sep 20, 2022

Medicine Called Infliximab[Infliximab Biosimilar 3] in People

Not yet recruiting
  • Arthritis, Rheumatoid
  • +3 more
    • (no location specified)
    Mar 31, 2023

    Sterile Corneal Melt Trial in Montreal (Topical Infliximab)

    Recruiting
    • Sterile Corneal Melt
    • Topical Infliximab
    • Montreal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal
    Dec 12, 2022

    IBD Trial in Saint Louis (Infliximab)

    Active, not recruiting
    • Inflammatory Bowel Diseases
    • Infliximab
    • Saint Louis, Missouri
      Washington University School of Medicine
    Aug 31, 2022

    Colitis Trial in Aalborg, Odense, London (Infliximab, Methylprednisolone, Prednisolone)

    Not yet recruiting
    • Colitis
    • Infliximab
    • +2 more
    • Aalborg, Denmark
    • +2 more
    Jul 7, 2023

    90K/Mac-2 BP asIndicator of Early Response to Infliximab Therapy

    Not yet recruiting
    • IBD
    • 90K
    • (no location specified)
    Jul 18, 2023

    Sarcoidosis Trial (STOP arm)

    Not yet recruiting
    • Sarcoidosis
    • STOP arm
    • (no location specified)
    Jan 16, 2023

    Psoriasis Trial in Lahore (Remsima)

    Completed
    • Psoriasis
    • Lahore, Punjab, Pakistan
      Ghurki Hospital
    Sep 12, 2023

    Idiopathic Refractory Scleritis Trial (Infliximab, Cyclophosphamide)

    Withdrawn
    • Idiopathic Refractory Scleritis
    • (no location specified)
    Jul 18, 2022

    Ulcerative Colitis Trial in Melbourne (Infliximab)

    Active, not recruiting
    • Ulcerative Colitis
    • Infliximab
    • Melbourne, Victoria, Australia
      Austin Health
    Jun 19, 2022

    Glaucoma Following Surgery Trial in Montréal (Topical infliximab, No topical infliximab)

    Recruiting
    • Glaucoma Following Surgery
    • Topical infliximab
    • No topical infliximab
    • Montréal, Quebec, Canada
      Centre Hospitalier de l'Université de Montréal
    Jul 4, 2022

    COVID-19 Trial in Jena (Infliximab, Standard of Care)

    Recruiting
    • COVID-19
    • Infliximab
    • Standard of Care
    • Jena, Germany
      Jena University Hospital
    Aug 10, 2022

    Infliximab in the Treatment of Chinese Crohn's Disease

    Active, not recruiting
    • Crohn Disease
    • Infliximab
    • Guangzhou, China
    • +4 more
    Jan 31, 2023

    IBD Trial in Leuven (Infliximab)

    Recruiting
    • Inflammatory Bowel Diseases
    • Infliximab
    • Leuven, Vlaanderen, Belgium
      UZ Leuven
    Feb 11, 2022

    Aneurysm, Stroke, Vasculitis Trial in San Francisco (Infliximab)

    Enrolling by invitation
    • Aneurysm
    • +3 more
    • Infliximab
    • San Francisco, California
      UCSF Medical Center
    Apr 25, 2022

    Biomarkers to Predict and Monitor Response to Infliximab

    Recruiting
    • Crohn Disease
    • Infliximab
    • Boston, Massachusetts
      MassGeneral for Children
    Apr 5, 2022